BoniEElewskiMD
Dermatology • Birmingham, ALProfessor, Dermatology, University of Alabama School of Medicine
Dr. Elewski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 6th Ave S
Birmingham, AL 35233Phone+1 800-822-8816
Summary
- Dr. Boni Elewski is a dermatologist in Birmingham, AL and is affiliated with multiple hospitals in the area, including Birmingham Veterans Affairs Medical Center and University of Alabama Hospital. She received her medical degree from The Ohio State University College of Medicine and has been in practice 39 years. She is experienced in general dermatology and complex medical dermatology.
Education & Training
University of North Carolina HospitalsResidency, Dermatology, 1979 - 1982- University of North Carolina HospitalsInternship, Internal Medicine, 1978 - 1979
Ohio State University College of MedicineClass of 1978
Certifications & Licensure
CA State Medical License 1989 - Present
OH State Medical License 1982 - 2027
AL State Medical License 1999 - 2025
NC State Medical License 1978 - 2002- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Ketoconazole Foam 2% for the Treatment of Versicolor Start of enrollment: 2008 Nov 01
- Can We Miss Pigmented Lesions in Psoriasis Patients? Start of enrollment: 2007 Sep 01
- Epiduo Pediatric Acne Study Start of enrollment: 2010 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Bimekizumab Efficacy in High-Impact Areas: Pooled 2-Year Analysis in Scalp, Nail, and Palmoplantar Psoriasis from Phase 3/3b Randomized Controlled Trials.Joseph F Merola, Alice B Gottlieb, Andreas Pinter, Boni Elewski, Melinda Gooderham
Dermatology and Therapy. 2024-12-01 - CD2 expressing innate lymphoid and T cells are critical effectors of immunopathogenesis in hidradenitis suppurativa.Mahendra Pratap Kashyap, Bharat Mishra, Rajesh Sinha, Lin Jin, YiFei Gou
Proceedings of the National Academy of Sciences of the United States of America. 2024-11-26 - A tribute to Dr Robert Baran: The grandfather of European onychology.Mark Holzberg, Boni Elewski, Carlton Ralph Daniel 3rd, Nathaniel J Jellinek, Shari R Lipner
Journal of the American Academy of Dermatology. 2024-09-01
Journal Articles
- Association of Secukinumab Treatment with Tuberculosis Reactivation in Patients with Psoriasis, Psoriatic Arthritis, or Ankylosing SpondylitisBoni Elewski, MD, JAMA Dermatology
Lectures
- Infectious DiseasesAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
- Women's & Pediatric Dermatology Seminar 2013Global Academy for Medical Education (Elsevier), Newport Beach, California - 10/4/2013
- Twenty-Second Annual Summer MeetingWest Virginia Dermatologic Society, White Sulphur Springs, West Virginia - 8/24/2012
Press Mentions
Study Reveals the Disruption of Interaction Between Proteins CD2:CD58 Is a Potential New Treatment Option for People with Hidradenitis SuppurativaNovember 19th, 2024- Increase in Troublesome Fungal Infections Requires All-Out ApproachOctober 25th, 2024
- Drug-Resistant Fungus Is Raising International ConcernAugust 30th, 2024
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
